hydralazine has been researched along with adrenomedullin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohi, K; Horio, T; Kangawa, K; Matsuo, H; Morimoto, A; Nagaya, N; Nishikimi, T; Yoshihara, F | 1 |
| Akishita, M; Imai, Y; Ishibashi, S; Kangawa, K; Kurihara, H; Kurihara, Y; Maekawa, H; Maemura, K; Minamino, N; Morita, H; Nagai, R; Oh-hashi, Y; Osuga, J; Saito, Y; Sata, M; Shindo, T; Suzuki, T; Tobe, K; Yazaki, Y | 1 |
| Harris, AL; Knowles, HJ; Mole, DR; Tian, YM | 1 |
| Bell, D; Devine, AB; McDermott, BJ; McHenry, EM; Nicholls, DP; Smith, LR; Zhao, L; Zhao, Y | 1 |
4 other study(ies) available for hydralazine and adrenomedullin
| Article | Year |
|---|---|
Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats.
Topics: Adrenomedullin; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Calcitonin Gene-Related Peptide; Data Interpretation, Statistical; Gene Expression; Heart Ventricles; Hemodynamics; Hydralazine; Hypertrophy, Left Ventricular; Immunohistochemistry; Isoquinolines; Kidney; Male; Organ Size; Peptides; Prodrugs; Quinapril; Radioimmunoassay; Rats; Rats, Wistar; Renin; RNA, Messenger; Tetrahydroisoquinolines; Time Factors; Ventricular Pressure | 1999 |
Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin overexpression.
Topics: Adipose Tissue; Adrenomedullin; Animals; Apolipoproteins E; Calcitonin Gene-Related Peptide; Femoral Artery; Hydralazine; Hyperplasia; Mice; Mice, Knockout; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Peptides; Tunica Intima | 2002 |
Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Topics: Adrenomedullin; Angiogenesis Inducing Agents; Animals; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cell Hypoxia; Cell Line, Tumor; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelial Cells; Endothelin-1; Enzyme Inhibitors; Gene Expression Regulation; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Hydralazine; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Implants, Experimental; Kidney Neoplasms; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Myocytes, Smooth Muscle; Neovascularization, Physiologic; Nuclear Proteins; Peptides; Procollagen-Proline Dioxygenase; Transcription Factors; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2004 |
Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
Topics: Adrenomedullin; Animals; Body Weight; Hydralazine; Hydrochlorothiazide; Hypertension; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Myocytes, Cardiac; Myosin Heavy Chains; Neuropeptides; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Peptides; Rats; Rats, Sprague-Dawley; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Protein 2; Receptor Activity-Modifying Protein 3; Receptor Activity-Modifying Proteins; Receptors, Adrenomedullin; Receptors, Peptide; RNA, Messenger; Systole | 2006 |